In vitro effects of cyclosporine a and tacrolimus on regulatory t-cell proliferation and function

Transplantation

Volumn 94, Issue 2, 2012, Pages 123-131

  Miroux, Céline ^a   Morales, Olivier ^a   Ghazal, Khaldoun ^b   Othman, Samia Ben ^b   De Launoit, Yvan ^a   Pancré, Véronique ^a   Conti, Filomena ^b,c,d   Delhem, Nadira ^a  

^a UNIV LILLE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Cyclosporine A; HCV; Regulatory T cells; Transplantation

Indexed keywords

CYCLOSPORIN A [4 N METHYLISOLEUCINE]; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; DRUG SCREENING; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOPHENOTYPING; IN VITRO STUDY; LIVER TRANSPLANTATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

CALCINEURIN; CELLS, CULTURED; CYCLOSPORINE; CYTOKINES; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; NFATC TRANSCRIPTION FACTORS; PHOSPHORYLATION; T-LYMPHOCYTES, REGULATORY; TACROLIMUS;

EID: 84864278784     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182590d8f     Document Type: Article

References (44)

1. Haddad EM, McAlister VC, Renouf E, et al. Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev 2006; 4: CD005161.
2. O'Grady JG. Prognostication in acute liver failure: a tool or an anchor? Liver Transpl 2007; 6: 786.
3. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004; 8: 801.
4. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 4: 345.
5. Sakaguchi S, Sakaguchi N, Shimizu J, et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182: 18.
6. Stephens LA, Mottet C, Mason D, et al. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 2001; 4: 1247.
7. Miyara M, Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 2007; 3: 108.
8. Ziegler SF. FOXP3: not just for regulatory T cells anymore. Eur J Immunol 2007; 1: 21.
9. Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 7: 1693.
10. Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 7: 1701.
11. Itoh M, Takahashi T, Sakaguchi N, et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999; 9: 5317.
12. Fontenot JD, Rasmussen JP, Gavin MA, et al. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005; 11: 1142.
13. D'Cruz LM, Klein L. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol 2005; 11: 1152.
14. Velasquez-Lopera MM, Eaton VL, Lerret NM, et al. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+) Foxp3(+) regulatory T cells. Transpl Immunol 2008; 2: 127.
15. Joffre O, Santolaria T, Calise D, et al. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 2008; 1: 88.
16. Demirkiran A, Kok A, Kwekkeboom J, et al. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl 2006; 2: 277.
17. Stenard F, Nguyen C, Cox K, et al. Decreases in circulating CD4+ CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients. Pediatr Transplant 2009; 1: 70.
18. Zeiser R, Nguyen VH, Beilhack A, et al. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 2006; 1: 390.
19. Curry MP. Hepatitis B and hepatitis C viruses in liver transplantation. Transplantation 2004; 7: 955.
20. Velidedeoglu E, Mange KC, Frank A, et al. Factors differentially correlated with the outcome of liver transplantation in HCV+ and HCVj recipients. Transplantation 2004; 12: 1834.
21. Berenguer M. Outcome of posttransplantation hepatitis C virus diseaseVis it the host, the virus, or how we modify the host and/or the virus? Liver Transpl 2002; 10: 889.
22. Rodriguez-Luna H, Douglas DD. Natural history of hepatitis C following liver transplantation. Curr Opin Infect Dis 2004; 4: 363.
23. Carpentier A, Conti F, Stenard F, et al. Increased expression of regulatory Tr1 cells in recurrent hepatitis C after liver transplantation. Am J Transplant 2009; 9: 2102.
24. Firpi RJ, Soldevila-Pico C, Morelli GG, et al. The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study. Dig Dis Sci 2010; 1: 196.
25. Cabrera R, Tu Z, Xu Y, et al. An immunomodulatory role for CD4(+) CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004; 5: 1062.
26. Rushbrook SM, Ward SM, Unitt E, et al. Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 2005; 12: 7852.
27. Boettler T, Spangenberg HC, Neumann-Haefelin C, et al. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 2005; 12: 7860.
28. Manigold T, Racanelli V. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect Dis 2007; 12: 804.
29. Earle KE, Tang Q, Zhou X, et al. In vitro expanded human CD4+ CD25+ regulatory T cells suppress effector T cell proliferation. Clin Immunol 2005; 1: 3.
30. Hoffmann P, Eder R, Kunz-Schughart LA, et al. Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 2004; 3: 895.
31. Kohjima M, Enjoji M, Higuchi N, et al. NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells. Liver Int 2007; 27: 1273.
32. Kawai M, Kitade H, Mathieu C, et al. Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo. Transplantation 2005; 9: 1073.
33. Wang H, Zhao L, Sun Z, et al. A potential side effect of cyclosporin A: inhibition of CD4(+)CD25(+) regulatory T cells in mice. Transplantation 2006; 11: 1484.
34. San Segundo D, Ruiz JC, Fernandez-Fresnedo G, et al. Calcineurin inhibitors affect circulating regulatory T cells in stable renal transplant recipients. Transplant Proc 2006; 8: 2391.
35. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 2: 287.
36. Campbell DJ, Ziegler SF. FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat Rev Immunol 2007; 4: 305.
37. Bollyky PL, Falk BA, Long SA, et al. CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL- 2, IL-10, and TGF-beta. J Immunol 2009; 4: 2232.
38. Bettelli E, Dastrange M, Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci U S A 2005; 14: 5138.
39. Torgerson TR, Genin A, Chen C, et al. FOXP3 inhibits activationinduced NFAT2 expression in T cells thereby limiting effector cytokine expression. J Immunol 2009; 2: 907.
40. Sumpter TL, Payne KK, Wilkes DS. Regulation of the NFAT pathway discriminates CD4+CD25+ regulatory T cells from CD4+CD25j helper T cells. J Leukoc Biol 2008; 3: 708.
41. Rayhill SC, Barbeito R, Katz D, et al. A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C. Transplant Proc 2006; 10: 3625.
42. Villamil F, Levy G, Grazi GL, et al. Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine. Transplant Proc 2006; 9: 2964.
43. Coenen JJ, Koenen HJ, van Rijssen E, et al. Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells. Blood 2006; 3: 1018.
44. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 4: 402.